Belgium· BE-AMP-SAM263225-00

Cholestagel 625 mg

A colesevelam product containing colesevelam hydrochloride, registered in Belgium by Cheplapharm Arzneimittel. The same ATC class is registered in 14 of our 19 countries.

ATC C10AC04

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about colesevelam hydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Colesevelam is registered in 14 of 19 countries.

Countries holding a registration under ATC C10AC04 (colesevelam), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
8 of them publish a price we can compare per daily dose

Search colesevelam products by name

Colesevelam · ATC C10AC04

14 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Spainprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of colesevelam costs, country by country.

Normalised to the WHO defined daily dose (3.75 g), the median price runs from $1.57 in United States to $5.96 in Spain — a ×3.8 gap.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Colesevelam · price per daily dose (3.75 g)

USD · FX 28 Sept 2026

ES Spain$5.96
US United States$1.57 (acquisition cost)

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Colesevelam Hydrochloride
Manufacturer: Cheplapharm Arzneimittel
Country: Belgium (BE)
ATC code: C10AC04
ATC class: Colesevelam
Defined daily dose: 3.75 g, O
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

63 interactions on record for colesevelam.

Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check colesevelam against other medicines How interaction checks work

Colesevelam · interactions on record

63 records

5 severe
58 moderate

Most severe, free to view

BexaroteneL01XF03severe
BexarotenL01XX25severe
Mycophenolic acidL04AA06severe
TeriflunomidL04AA31severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Colesevelam in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All colesevelam products

Authorised across Europe · EMA

The same active substance is authorised in 5 EEA countries. Names it is sold under:

Germany · Colesevelamhydrochlorid Ascend
United Kingdom (Northern Ireland) · Colesevelam Hydrochloride Consilient Health, Colesevelam Hydrochloride Dr. Reddy's Laboratories (Uk)
Iceland · Cholestagel
Liechtenstein · Cholestagel
Norway · Cholestagel

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/a61b14cf-fd61-4f13-8eaa-84e1c060b58c
GET /v1/drugs/a61b14cf-fd61-4f13-8eaa-84e1c060b58c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Cholestagel 625 mg",
  "name_fr": "Cholestagel 625 mg",
  "name_nl": "Cholestagel 625 mg",
  "amp_code": "SAM263225-00",
  "strengths": [
    "625.0000",
    "625.0000"
  ],
  "pack_count": 4,
  "substances": [
    "Colesevelam Hydrochloride",
    "Propylene Glycol"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Colesevelam",
  "authorisation_numbers": [
    "EU/1/03/268/001",
    "EU/1/03/268/002",
    "EU/1/03/268/003",
    "EU/1/03/268/004"
  ]
}

API reference MCP server Plans

See everything about colesevelam.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console